Pancreatic Cancer Research

ResearcherUniversity of FreiburgActive in the last 2 years

Philipp Hafner

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0007-9989-6925; OpenAlex author ID A5029791189. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2025: 2 papers · 2026: 2 papers

Papers 4

  1. Vertical RAS pathway inhibition in pancreatic cancer drives therapeutically exploitable mitochondrial alterations. Co-author DOI 10.1038/s41392-025-02563-7↗
  2. Immunomodulatory impact of PTPN11 /SHP2-based vertical RAS-MAPK pathway inhibition in pancreatic cancer Co-author DOI 10.64898/2026.05.23.727401↗
  3. 19Fluorine-MRI Based Longitudinal Immuno-Microenvironment-Monitoring for Pancreatic Cancer. Co-author DOI 10.1002/jmri.29589↗
  4. Adaptive resistance to SHP2-based vertical RAS-pathway inhibition in pancreatic cancer involves multifaceted routes towards dedifferentiation Co-author DOI 10.1101/2025.09.09.25335395↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Wilfried Reichardt · 4 shared papers, 2025–2026 · strength 0.85
  2. Asma Y. Alrawashdeh · 4 shared papers, 2025–2026 · strength 0.85
  3. Dietrich Alexander Ruess · 4 shared papers, 2025–2026 · strength 0.85
  4. Melanie Boerries · 3 shared papers, 2025–2026 · strength 0.63
  5. Xun Chen · 2 shared papers, 2025 · strength 0.42
  6. Friederike Inga Nollmann · 1 shared paper, 2026 · strength 0.20
  7. Oliver Schilling · 1 shared paper, 2026 · strength 0.20
  8. Uwe A. Wittel · 1 shared paper, 2026 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.